-
Study aim
-
The effects of pharmacist care versus usual care in Iranians with type 2 diabetes for the prevention of cardiovascular diseases
-
Design
-
To randomize the study, each patient is assigned a code(1 or 2) using Rand number. Conventionally, a patient who received a code of one will receive the pharmacist's care for a period of three months. It should be noted that the patients will not know what code they have received and only the researcher will be aware of this issue.
-
Settings and conduct
-
The clinical trial has two intervention and control groups, community-based and practical, with a factorial group, unblinded, randomized, on 60 patients.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:patients with new-onset type 2 diabetes with an age range of 18-70 years.
Exclusion criteria: pregnant and lactating patients.
-
Intervention groups
-
intervention group: 30 type 2 diabetes patients who entered the study were initially checked for blood sugar, blood fat, blood pressure and the risk of cardiovascular disease, and received the care of a pharmacist for three months, and at the end of three months, again in terms of blood sugar, blood fat, blood pressure and cardiovascular risk were examined.
Control group:30 type 2 diabetes patients who were included in the study were initially checked for blood sugar, blood fat, blood pressure and risk of cardiovascular disease, and they had routine care for three months and did not receive pharmaceutical care. At the end of three months, blood sugar, blood fat, and blood pressure and cardiovascular risk were investigated.
-
Main outcome variables
-
Reduction in fasting blood sugar and HbA1c, cholesterol and triglycerides, blood pressure and prediction of cardiovascular risk (FRC).